XML 54 R44.htm IDEA: XBRL DOCUMENT v3.19.2
Acquisitions and Divestiture (Asset Acquisitions) (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2019
Mar. 31, 2019
Jan. 31, 2019
Jun. 30, 2018
Apr. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Business Acquisition [Line Items]                  
Acquired in-process research and development           $ 25.0 $ 1,624.5 $ 161.9 $ 1,624.5
AC Immune SA                  
Business Acquisition [Line Items]                  
Acquired in-process research and development     $ 96.9            
ImmuNext, Inc.                  
Business Acquisition [Line Items]                  
Acquired in-process research and development   $ 40.0              
Avidity Biosciences, Inc.                  
Business Acquisition [Line Items]                  
Acquired in-process research and development $ 25.0                
Sigilon Therapeutics                  
Business Acquisition [Line Items]                  
Acquired in-process research and development         $ 66.9        
AurKa Pharma, Inc.                  
Business Acquisition [Line Items]                  
Acquired in-process research and development       $ 81.8          
ARMO Biosciences, Inc.                  
Business Acquisition [Line Items]                  
Acquired in-process research and development       $ 1,475.8